Biotech grants in Switzerland
Explore Biotech grants for companies in Switzerland. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Swiss innovation agencies, research funders and foundations, international programs open to applicants in Switzerland, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Switzerland come first.
Showing 241-264 of 569 grants
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies
NIH · United States
Funds functional testing of genetic variants linked to congenital anomalies, to separate the ones that matter from the ones that merely appear.
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
FDA · United States
Funds natural history studies that track how a rare disease unfolds over time, to close data gaps blocking new treatments for it.
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders
NIH · United States
Funds no new studies directly — it grants approved investigators access to NIH's shared genetic and multi-omics data on heart, lung, blood and sleep disorders.
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
FDA · United States
Funds clinical trials testing whether a product works and is safe for a rare disease, aimed at a new indication or a labeling change.
INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research
NIH · United States
Funds planning then running a milestone-driven clinical trial for a health condition that co-occurs with Down syndrome.
INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome
NIH · United States
Funds early, exploratory Down syndrome research — a novel idea or new use of an existing method, even where the answer is unproven.
INCLUDE Project: Transformative Research Awards for Down syndrome
NIH · United States
Funds bold, unconventional Down syndrome research that could open an entirely new scientific or clinical direction.
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose
NIH · United States
Funds discovering and developing a medication or device to prevent or treat substance use disorders and overdose, in two phases.
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders)
NIH · United States
Funds high-risk, high-reward research on HIV prevention, diagnosis or treatment in people who use substances or have a substance use disorder.
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
NIH · United States
Funds secondary analysis of archived HIV/AIDS data and specimens from maternal, pediatric and adolescent populations, without collecting anything new.
Early Immune System Development and Ontogeny
NIH · United States
Funds research into how the immune system forms in the womb, infancy and early childhood, including under HIV or antiretroviral exposure.
The Metastasis Research Network (MetNet): MetNet Research Projects
NIH · United States
Funds a research project that plugs into NCI's Metastasis Research Network of systems-level cancer centers, up to $500,000.
Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research
NIH · United States
Funds new bioinformatics, computational biology, or AI methods that turn messy biomedical datasets into usable knowledge.
Biological Testing Facility for Contraception & Reproductive Health
NIH · United States
Funds access to NIH's own Biological Testing Facility for contraceptive or reproductive-health work — a service award, open to applicants worldwide.
Bioengineering Research Grants (BRG)
NIH · United States
Funds small multidisciplinary teams applying bioengineering to a specific biomedical, translational or clinical problem, up to $500,000.
NIAID Clinical Trial Implementation Cooperative Agreement
NIH · United States
Funds running an investigator-initiated, milestone-driven clinical trial that needs closer NIH oversight, including any mechanistic sub-studies.
AI for Health — Azure Credit Award
AI for Good Lab · United States
Supports global health nonprofits and researchers with AI compute resources and scientific collaboration opportunities.
Career Development and Transition Funding
Coefficient · United States
Supports professionals and students transitioning into global catastrophic risk careers.
CEPI Open Calls for Proposals
CEPI · Norway
Funds global vaccine and biologic countermeasure developers to build responses for epidemic pathogens.
Global Catastrophic Risks Opportunities Fund — Career Development & Transition
Coefficient · United States
Funds individual transitions into global catastrophic risk work through career development support.
IBD Ventures
CCF · United States
Administers startup and industry teams with commercialization support for IBD Ventures in biotechnology and medical technology.
Lead Exposure Action Fund (LEAF) — Proactive Grants
Coefficient · United States
Funds practical lead exposure projects in low and middle income communities with testing and mitigation.
MIT.nano Industry Consortium / Foundry Access
MIT.nano · United States
Provides Massachusetts startup teams access to advanced prototyping and fabrication through MIT.nano collaboration.
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks
NIH · United States
Funds a multi-center clinical trial or ancillary study run inside an already-funded NIH Clinical Trial Research Network, in two milestone-driven phases.